PEGA insider files Form 4: option exercises and 47,692-share disposition

Rhea-AI Filing Summary

Pegasystems (PEGA) Chief Product Officer Rifat Kerim Akgonul filed a Form 4 reporting multiple option exercises and a share disposition on 10/24/2025. He exercised stock options for 25,000 shares at $26.24, 15,000 shares at $29.48, 10,000 shares at $32.18, and 20,000 shares at $16.95 (transaction code M). He also disposed of 47,692 shares at $65.61 (code F).

Following these transactions, beneficial ownership stood at 113,688 shares, held directly. The options exercised relate to grants with vesting schedules noted: certain grants vested 20% on the initial exercisability date with the remaining 80% in equal quarterly installments over four years, and one grant vesting in equal quarterly amounts over four years from its initial exercisability date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Akgonul Rifat Kerim

(Last) (First) (Middle)

C/O PEGASYSTEMS INC.

225 WYMAN STREET, STE 300

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PEGASYSTEMS INC [ PEGA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/24/2025		M		25,000	A	$26.24	116,380	D
Common stock	10/24/2025		M		15,000	A	$29.48	131,380	D
Common stock	10/24/2025		M		10,000	A	$32.18	141,380	D
Common stock	10/24/2025		M		20,000	A	$16.95	161,380	D
Common stock	10/24/2025		F		47,692	D	$65.61	113,688	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$26.24	10/24/2025		M			25,000	06/05/2023(1)	06/05/2032	Common stock	25,000	$0	50,000	D
Stock Options	$29.48	10/24/2025		M			15,000	03/05/2019(1)	03/05/2028	Common stock	15,000	$0	13,908	D
Stock Options	$32.18	10/24/2025		M			10,000	03/06/2020(1)	03/06/2029	Common stock	10,000	$0	25,190	D
Stock Options	$16.95	10/24/2025		M			20,000	02/02/2023(2)	11/02/2032	Common stock	20,000	$0	115,364	D

Explanation of Responses:

1. Options vested 20% on the Date Exercisable in Table II, with the remaining 80% vesting in equal quarterly amounts over the next four years.

2. Option vests in equal quarterly amounts over a four-year period with the first vest occurring on the Date Exercisable in Table II.

Remarks:

	/s/Kathryn Leach, Attorney-in-Fact for Rifat Kerim Akgonul	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PEGA’s Chief Product Officer report on Form 4?

He reported exercising options for 25,000 at $26.24, 15,000 at $29.48, 10,000 at $32.18, and 20,000 at $16.95, and disposing of 47,692 shares at $65.61.

What is the final beneficial ownership after the transactions for PEGA?

Beneficial ownership following the reported transactions is 113,688 shares, held directly.

When did the reported PEGA transactions occur?

All transactions were dated 10/24/2025.

What was the nature of the 47,692 PEGA shares transaction?

It was a disposition coded F at $65.61 per share.

What vesting terms are disclosed for the exercised PEGA options?

One set vested 20% on the initial date with 80% quarterly over four years; another vests in equal quarterly amounts over four years from its initial date.

What role does the reporting person hold at PEGA?

He is an Officer, serving as Chief Product Officer.